2011Wuhan Daxue xuebao. Yixue banRequires access

Effects of Calcium Dobesilate on Renal Injury in Patients with Diabetic Nephropathy

Yang Renyong

Open publisher page 0 citations

Abstract

Objective: To study the effects of calcium dobesilate on renal injury in patients with diabetic nephropathy.Methods: Sixty-four cases of patients with stage Ⅲ and stage Ⅳ diabetic nephropathy were selected and were randomly divided into treatment group(1.5 g of calcium dobesilate daily) and control group.Urine albumin excretion(UAE),24-hour urine protein(TP/24h),blood rheology,alanine aminotransferase(ALT),aspartate aminotransferase(AST),blood urea nitrogen(BUN),and serum creatinine(Scr) in both groups were monitored.Results: Twelve weeks after treatment,UAE in treatment group at stage Ⅲ was(176±28) μg/min,which was significantly lower than that of control group at stage Ⅲ([126±21] μg/min,P0.05).TP/24h of treatment group at stage Ⅳ was(0.79±0.09) g(P0.05,vs [0.83±0.11] g in control group).The whole blood viscosity and plasma viscosity were decreased significantly after the treatment of calcium dobesilate in both stage Ⅲ and stage Ⅳ patients(P0.05).However,calcium dobesilate treatment didn't have significant influence on ALT,AST,BUN,and Scr(P0.05).Conclusion: Calcium dobesilate has advantages on treating patients with diabetic nephropathy stage Ⅲ.

About this research paper

What this paper is about

Objective: To study the effects of calcium dobesilate on renal injury in patients with diabetic nephropathy.Methods: Sixty-four cases of patients with stage Ⅲ and stage Ⅳ diabetic nephropathy were selected and were randomly divided into treatment group(1.5 g of calcium dobesilate daily) and control group.Urine albumin excretion(UAE),24-hour urine protein(TP/24h),blood rheology,alanine aminotransferase(ALT),aspartate aminotransferase(AST),blood urea nitrogen(BUN),and serum creatinine(Scr) in both groups were monitored.Results: Twelve weeks after treatment,UAE in treatment group at stage Ⅲ was(176±28) μg/min,which was significantly lower than that of control group at stage Ⅲ([126±21] μg/min,P0.05).TP/24h of treatment group at stage Ⅳ was(0.79±0.09) g(P0.05,vs [0.83±0.11] g in control group).The whole blood viscosity and plasma viscosity were decreased significantly after the treatment of calcium dobesilate in both stage Ⅲ and stage Ⅳ patients(P0.05).However,calcium dobesilate treatment didn't have significant influence on ALT,AST,BUN,and Scr(P0.05).Conclusion: Calcium dobesilate has advantages on treating patients with diabetic nephropathy stage Ⅲ.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To study the effects of calcium dobesilate on renal injury in patients with diabetic nephropathy.Methods: Sixty-four cases of patients with stage Ⅲ and stage Ⅳ diabetic nephropathy were selected and were randomly divided into treatment group(1.5 g of calcium dobesilate daily) and control group.Urine albumin excretion(UAE),24-hour urine protein(TP/24h),blood rheology,alanine aminotransferase(ALT),aspartate aminotransferase(AST),blood urea nitrogen(BUN),and serum creatinine(Scr) in both groups were monitored.Results: Twelve weeks after treatment,UAE in treatment group at stage Ⅲ was(176±28) μg/min,which was significantly lower than that of control group at stage Ⅲ([126±21] μg/min,P0.05).TP/24h of treatment group at stage Ⅳ was(0.79±0.09) g(P0.05,vs [0.83±0.11] g in control group).The whole blood viscosity and plasma viscosity were decreased significantly after the treatment of calcium dobesilate in both stage Ⅲ and stage Ⅳ patients(P0.05).However,calcium dobesilate treatment didn't have significant influence on ALT,AST,BUN,and Scr(P0.05).Conclusion: Calcium dobesilate has advantages on treating patients with diabetic nephropathy stage Ⅲ.

Key concepts: Diabetic nephropathy, Creatinine, Blood urea nitrogen, Medicine, Internal medicine, Albumin, Calcium, Urine

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of Calcium Dobesilate on Renal Injury in Patients with Diabetic Nephropathy — Research Paper | ScholarLens